The Guernsey-based fund is advised by the Bellevue Asset Management Group and is dedicated to investing in companies that develop and market drugs, medical devices, and healthcare services. BB BIOTECH VENTURES has a team of investment advisors and an advisory board, as well as access to the Group's healthcare investment experts and a network of specialists and advisors. The fund's primary goal is to maximize returns for its investors through hard work, experience, networking, and a focus on value creation.